23:36:49 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Imagin Medical Inc
Symbol IME
Shares Issued 139,060,278
Close 2019-04-16 C$ 0.085
Market Cap C$ 11,820,124
Recent Sedar Documents

Imagin appoints Kamat to scientific advisory board

2019-04-17 08:52 ET - News Release

Mr. Jim Hutchens reports

IMAGIN MEDICAL WELCOMES WORLD-RENOWNED BLADDER CANCER EXPERT DR. ASHISH M. KAMAT TO ITS SCIENTIFIC BOARD OF ADVISORS

Dr. Ashish M. Kamat has joined Imagin Medical Inc.'s scientific advisory board.

Dr. Kamat has been named by Expertscape as the world's top-rated expert in urinary bladder neoplasms. Dr. Kamat has extensive experience with cystoscopic procedures, has been a principal investigator for multiple oncology and urology clinical studies for both drugs and devices, and has been involved in blue light cystoscopy studies since 2007.

Dr. Kamat is an endowed professor of urologic oncology and cancer research at University of Texas MD Anderson Cancer Centre (MDACC); associate cancer centre director, RFHNH in Mumbai, and president of International Bladder Cancer Group (IBCG) and International Bladder Cancer Network (IBCN). He is associate editor for European Urology Oncology, directed the MDACC urologic oncology fellowship from 2005 to 2016 and is an alumnus of the American Urological Association leadership program.

Dr. Kamat received his medical degree at the University of Bombay, India's Seth G.S. Medical College & King Edward Memorial Hospital, and completed a fellowship in urologic oncology at the MD Anderson Cancer Centre. Dr. Kamat focuses on bladder cancer, immunotherapy and organ sparing therapies. He has led several national and international studies, which have been reported in high-impact journals. Dr. Kamat has over 300 publications, is listed in "Who's Who in Medicine" and "Best Doctors in America," and has won the compassionate doctor award from patient groups.

"The advent of enhanced cystoscopy, especially photodynamic diagnosis, has provided us with a means to better detect, diagnose and treat our patients who have bladder cancer," said Dr. Kamat. "The technology being developed by the team at Imagin has the potential to allow this technology to be adopted by many centres which currently are not able to do so."

"We are honoured to have Dr. Kamat, a worldwide bladder cancer expert, join our scientific advisory board," said Jim Hutchens, Imagin's president and chief executive officer. "Dr. Kamat has extensive experience with cystoscopy, so his expertise will be invaluable as we progress the development of the company's i/Blue imaging system."

"I am excited to join Imagin's scientific board of advisers and look forward to supporting Imagin as it advances i/Blue to commercialization," said Dr. Kamat.

About Imagin Medical Inc.

Imagin Medical is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The company believes its first product, the i/Blue imaging system, will dramatically improve surgeons' ability to visualize cancerous cells by producing higher-quality images more quickly compared with current methods.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.